All UK & Rest of Europe articles – Page 58
-
NewsRisk of death reduces after COVID-19 vaccine but protection wanes after six months
The risk of death from COVID-19 decreases significantly after vaccination but this protection diminishes after six months, providing evidence for continued booster doses, a new study has found.
-
NewsAncient DNA reveals how a chicken virus evolved to become more deadly
Scientists have used ancient DNA to trace the evolution of Marek’s Disease Virus (MDV), showing how viruses evolve to become more virulent and could lead to the development of better ways to treat viral infections.
-
NewsDiverse gut bacteria communities protect against harmful pathogens by nutrient blocking
A new study demonstrates that diverse communities of resident bacteria can protect the human gut from disease-causing microorganisms. However, this protective effect is lost when only single species of gut bacteria are present.
-
NewsCockroaches can transmit antimicrobial resistance genes between groups
A new paper describes a study of antimicrobial resistance (AMR) transmission among cockroaches, with implications for AMR transmission in humans.
-
NewsInfection with stomach bacteria may increase risk of Alzheimer’s disease
Infection with the stomach bacterium Helicobacter pylori could increase the risk of developing Alzheimer’s disease. In people over the age of 50, the risk following a symptomatic infection can be an average of 11 per cent higher.
-
NewsDr Thomas Thompson named as winner of inaugural John Snow Prize
Dr Thomas Thompson of Queen’s University Belfast in Northern Ireland has been named as this year’s winner of the inaugural John Snow Prize for microbiology. The prize is part of the Applied Microbiology International Horizon Awards, which celebrate the brightest minds in the field and promote the ...
-
News€20 million EIB venture debt financing to support microbiome research and development
The EIB has signed €20 million in venture debt financing with Belgian microbiome health company The Akkermansia Company to accelerate the R&D and commercial activities around the Akkermansia muciniphila bacterium.
-
NewsCall for papers for themed Pseudomonas collection in Letters in Applied Microbiology
The journal Letters in Applied Microbiology is to run a themed collection on ’Emerging Horizons in Pseudomonas Biotechnology – Innovations from Early-Career Researchers’.
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsPatients can pause immune-suppressing medicines for COVID-19 booster vaccine
A major clinical trial shows that people with inflammatory conditions are able to improve the antibody response from a COVID-19 booster vaccination by interrupting their treatment for two weeks immediately after having the vaccine.
-
NewsAdvanced MRI technology detects changes in the brain after COVID-19
Researchers have found differences in brain tissue structure between patients with persisting symptoms after COVID-19 and healthy people.
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
NewsScientists find new, better way to develop vaccines
Researchers have developed a new system to display epitopes in mammal cells for immunization studies and believe that this method can help scientists greatly in immunization efforts.
-
NewsCovid persistence in lungs linked to failure of innate immunity
A new study shows that SARS-CoV-2 is found in the lungs of certain individuals for up to 18 months after infection, and that its persistence appears to be linked to a failure of innate immunity (the first line of defense against pathogens).
-
NewsFirst results in using new tools to tackle respiratory syncytial virus
Vaccines for pregnant women and use of monoclonal antibodies have been approved for use in the European Union to prevent respiratory syncytial virus (RSV) among young children. Are those tools working?
-
News40 years after the discovery of HIV, research raises hopes of remission
The conference ’40 years of HIV science’ was an opportunity to look back at the major advances that are raising hopes of remission and a cure for HIV.
-
NewsNew study considers risks of colistin and carbapenem resistance posed by aquatic farms
Aquatic farms could serve as a potential reservoir of colistin and carbapenem resistance, a new study warns. The review, by researchers at the University of Manchester, ‘An Update on the Prevalence of Colistin and Carbapenem-Resistant Gram-Negative Bacteria in Aquaculture: an Emerging Threat to Public Health’, has been accepted by the ...
-
NewsUK funds £15.6 million boost for low-emission food production systems
Innovate UK and BBSRC are set to invest £15.6 million as part of the novel low-emission food production systems competition, backing 32 innovative projects that produce foods in a more environmentally friendly way.
-
NewsZinc shows promise as surprising emerging treatment for vaginal yeast infections
New research could one day pave the way for the treatment of vaginal yeast infections, by shedding new light on how microbes in the body absorb zinc.
-
NewsFungus-fighting protein could help overcome severe autoimmune disease and cancer
A protein in the immune system programmed to protect the body from fungal infections is also responsible for exacerbating the severity of certain autoimmune diseases such as irritable bowel disease (IBS) and type 1 diabetes.